These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


376 related items for PubMed ID: 24417680

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Freeze-Drying of L-Arginine/Sucrose-Based Protein Formulations, Part 2: Optimization of Formulation Design and Freeze-Drying Process Conditions for an L-Arginine Chloride-Based Protein Formulation System.
    Stärtzel P, Gieseler H, Gieseler M, Abdul-Fattah AM, Adler M, Mahler HC, Goldbach P.
    J Pharm Sci; 2015 Dec; 104(12):4241-4256. PubMed ID: 26422647
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The influence of lysozyme on mannitol polymorphism in freeze-dried and spray-dried formulations depends on the selection of the drying process.
    Grohganz H, Lee YY, Rantanen J, Yang M.
    Int J Pharm; 2013 Apr 15; 447(1-2):224-30. PubMed ID: 23500620
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Screening of novel excipients for freeze-dried protein formulations.
    Holm TP, Meng-Lund H, Rantanen J, Jorgensen L, Grohganz H.
    Eur J Pharm Biopharm; 2021 Mar 15; 160():55-64. PubMed ID: 33508435
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effect of mannitol crystallization in mannitol-sucrose systems on LDH stability during freeze-drying.
    Al-Hussein A, Gieseler H.
    J Pharm Sci; 2012 Jul 15; 101(7):2534-44. PubMed ID: 22535541
    [Abstract] [Full Text] [Related]

  • 14. Impact of dextran on thermal properties, product quality attributes, and monoclonal antibody stability in freeze-dried formulations.
    Haeuser C, Goldbach P, Huwyler J, Friess W, Allmendinger A.
    Eur J Pharm Biopharm; 2020 Feb 15; 147():45-56. PubMed ID: 31866444
    [Abstract] [Full Text] [Related]

  • 15. Fuzzy Logic-based expert system for evaluating cake quality of freeze-dried formulations.
    Trnka H, Wu JX, Van De Weert M, Grohganz H, Rantanen J.
    J Pharm Sci; 2013 Dec 15; 102(12):4364-74. PubMed ID: 24258283
    [Abstract] [Full Text] [Related]

  • 16. Freeze-drying of tert-butyl alcohol/water cosolvent systems: effects of formulation and process variables on residual solvents.
    Wittaya-Areekul S, Nail SL.
    J Pharm Sci; 1998 Apr 15; 87(4):491-5. PubMed ID: 9548903
    [Abstract] [Full Text] [Related]

  • 17. Excipients for Room Temperature Stable Freeze-Dried Monoclonal Antibody Formulations.
    Haeuser C, Goldbach P, Huwyler J, Friess W, Allmendinger A.
    J Pharm Sci; 2020 Jan 15; 109(1):807-817. PubMed ID: 31622600
    [Abstract] [Full Text] [Related]

  • 18. Optimization of a pharmaceutical freeze-dried product and its process using an experimental design approach and innovative process analyzers.
    De Beer TR, Wiggenhorn M, Hawe A, Kasper JC, Almeida A, Quinten T, Friess W, Winter G, Vervaet C, Remon JP.
    Talanta; 2011 Feb 15; 83(5):1623-33. PubMed ID: 21238761
    [Abstract] [Full Text] [Related]

  • 19. Use of subambient differential scanning calorimetry to monitor the frozen-state behavior of blends of excipients for freeze-drying.
    Martini A, Kume S, Crivellente M, Artico R.
    PDA J Pharm Sci Technol; 1997 Feb 15; 51(2):62-7. PubMed ID: 9146035
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.